Merck (UKEX:MRK) Cyclically Adjusted Book per Share: ₴699.08 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UKEX:MRK Merck & Co Inc UKEX:MRK
73 GF Score
Price ₴4,844.00
GF Value ₴4,649.63
! 8 Warning Signs
View Full Analysis

What is Merck Cyclically Adjusted Book per Share?

Merck UKEX:MRK 73 Cyclically Adjusted Book per Share is ₴699.08 as of Mar. 2026. GuruFocus rates UKEX:MRK with a GF Score™ of 73/100 and a GF Value™ of ₴4,649.63. The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Merck's adjusted book value per share for the three months ended in Mar. 2026 was ₴827.228. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₴699.08 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Merck's average Cyclically Adjusted Book Growth Rate was 2.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 0.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 1.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 0.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Merck was 11.30% per year. The lowest was -1.00% per year. And the median was 6.40% per year.

As of today (2026-07-16), Merck's current stock price is ₴4844.00. Merck's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ₴699.08. Merck's Cyclically Adjusted PB Ratio of today is 6.93.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Merck was 7.82. The lowest was 3.04. And the median was 4.75.


Merck  (UKEX:MRK) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Merck's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4844.00/699.08
=6.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Merck was 7.82. The lowest was 3.04. And the median was 4.75.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Merck Cyclically Adjusted Book per Share Related Terms


Merck Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Merck's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck Cyclically Adjusted Book per Share Chart

Merck Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 580.30 590.23 821.94 787.85

Merck Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 917.96 1,045.78 991.54 787.85 699.08

UKEX:MRK vs AMGN, ABBV, GILD: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Merck's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Merck's Cyclically Adjusted PB Ratio falls into.


UKEX:MRK
73GF Score
Merck & Co Inc UKEX:MRK
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merck Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merck's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=827.228/330.2130*330.2130
=827.228

Current CPI (Mar. 2026) = 330.2130.

Merck Quarterly Data

Book Value per Share CPI Adj_Book
201606 698.119 241.018 956.476
201609 705.362 241.428 964.758
201612 649.450 241.432 888.270
201703 647.337 243.801 876.777
201706 644.389 244.955 868.672
201709 624.715 246.819 835.791
201712 567.016 246.524 759.504
201803 556.837 249.554 736.814
201806 542.521 251.989 710.934
201809 543.035 252.439 710.339
201812 458.630 251.233 602.809
201903 474.762 254.202 616.724
201906 479.438 256.143 618.079
201909 468.514 256.759 602.547
201912 454.376 256.974 583.876
202003 462.335 258.115 591.477
202006 486.694 257.797 623.408
202009 513.759 260.280 651.798
202012 445.571 260.474 564.868
202103 474.021 264.877 590.946
202106 585.379 271.696 711.456
202109 631.186 274.310 759.819
202112 672.723 278.802 796.773
202203 720.054 287.504 827.019
202206 760.166 296.311 847.139
202209 781.464 296.808 869.416
202212 807.000 296.797 897.859
202303 821.916 301.836 899.188
202306 678.517 305.109 734.345
202309 724.465 307.789 777.246
202312 661.045 306.746 711.617
202403 709.699 312.332 750.329
202406 765.388 314.175 804.460
202409 782.662 315.301 819.678
202412 815.928 315.605 853.694
202503 855.462 319.799 883.319
202506 871.591 322.561 892.267
202509 928.273 324.800 943.743
202512 946.650 324.054 964.642
202603 827.228 330.213 827.228

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₴699.08 mean?
Merck (UKEX:MRK) has a Cyclically Adjusted Book per Share of ₴699.08 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Merck and its competitors.
Is Merck's Cyclically Adjusted Book per Share too high?
Merck's current Cyclically Adjusted Book per Share is ₴699.08. Overall, Merck has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Merck's Cyclically Adjusted Book per Share compare to AMGN and ABBV?
Merck's Cyclically Adjusted Book per Share of ₴699.08 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Merck and its competitors. Merck's current Cyclically Adjusted Book per Share is ₴699.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck stock overvalued right now?
Merck (UKEX:MRK) has a current Cyclically Adjusted Book per Share of ₴699.08. The stock's GF Value™ is ₴4,649.63, compared to a current price of ₴4,844.00 — trading 4.2% above its estimated fair value. The current Cyclically Adjusted Book per Share is ₴699.08. Merck's overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Merck (UKEX:MRK), the current Cyclically Adjusted Book per Share is ₴699.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merck (UKEX:MRK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of ₴4,844.00 is trading 4.2% above its estimated GF Value™ of ₴4,649.63.

Key valuation signals for UKEX:MRK:

  • Cyclically Adjusted Book per Share: ₴699.08
  • GF Value™: ₴4,649.63 vs. price of ₴4,844.00 (4.2% above fair value)
  • GF Score™: 73/100 with 8 warning signs

No single metric tells the full story. See the UKEX:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
73GF Score

Get the complete analysis for UKEX:MRK

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₴4,844.00
Price
₴4,649.63
GF Value